Luye Pharma Group (HK:2186) has released an update.
Luye Pharma Group has announced plans to issue convertible bonds worth $150 million, with a 5.85% interest rate due in 2025. The proceeds will be used for refinancing existing debt, research and development, and general corporate purposes. The bonds, which can be converted into shares, are part of a strategic move to strengthen the company’s financial position.
For further insights into HK:2186 stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
